Introduction UroGen Pharma (NASDAQ:URGN) is a biotech company focused on developing innovative solutions for urothelial and specialty cancers. They’ve developed RTGel, a proprietary reverse-thermal...
By Ronnie Harui SINGAPORE–Singapore’s employment expanded at a slower pace in the second quarter than in the previous quarter, reflecting the impact of global...
The Biden administration on Thursday announced new actions to protect renters, including efforts the White House said could allow tenants greater opportunities to correct...
Investing.com – The bulls in U.S. natural gas can’t seem to break beyond mid-$2 pricing. Weather forecasts indicating August temperatures may be lower than...
Mark Yusko, the principal of Morgan Creek Capital Management, a fund management organization with $1.6 billion in its custody, shared some thought-provoking predictions about...
Bristol Myers Squibb stock fell Thursday after the drugmaker reported lower-than-expected second-quarter sales and cut its financial outlook based on competition from generic alternatives....